Stock-Based Compensation (Details) - USD ($) $ / shares in Units, $ in Millions | 3 Months Ended | 9 Months Ended |
Sep. 30, 2016 | Sep. 30, 2015 | Sep. 30, 2016 | Sep. 30, 2015 |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | |
Common Shares Available for Grant | | 21,400,000 | | 21,400,000 | |
Compensation expense related to the company's stock-based compensation plans | | $ 37.6 | $ 40.3 | $ 97.1 | $ 102 |
Stock Options and SARs [Member] | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | |
Unrecognized compensation expense | | 106.1 | | $ 106.1 | |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | | | | 3 years | |
Stock-based compensation expense related to stock options, SAR and ESPP grants | | $ 18.8 | $ 20 | $ 45 | $ 43.3 |
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract] | | | | | |
Weighted Average Fair Value of Grants (price per share) | | | | $ 25.77 | $ 21.87 |
Expected Volatility (in hundredths) | | | | 31.52% | 38.04% |
Risk-Free Interest Rate (in hundredths) | | | | 0.78% | 0.83% |
Dividend Yield (in hundredths) | | | | 0.76% | 0.85% |
Expected Life (in years) | | | | 5 years 4 months 24 days | 5 years 3 months 18 days |
Stock Options and SARs Rollforward [Abstract] | | | | | |
Outstanding at January 1 (in shares) | | | | 10,744,000 | 10,493,000 |
Granted (in shares) | | | | 1,821,000 | 2,029,000 |
Exercised (1) (in shares) | [1] | | | (1,673,000) | (1,291,000) |
Forfeited (in shares) | | | | (241,000) | (203,000) |
Outstanding at September 30 (2) (in shares) | [2] | 10,651,000 | 11,028,000 | 10,651,000 | 11,028,000 |
Stock Options and SARs Vested or Expected to Vest (in shares) | [3] | 10,300,000 | 10,653,000 | 10,300,000 | 10,653,000 |
Stock Options and SARs Exercisable at September 30 (in shares) | [4] | 6,302,000 | 6,121,000 | 6,302,000 | 6,121,000 |
Weighted Average Grant Price Stock Option and SARs [Rollforward] | | | | | |
Outstanding at January 1 (price per share) | | | | $ 67.98 | $ 64.96 |
Granted (price per share) | | | | 94.87 | 69.95 |
Exercised (1) (price per share) | [1] | | | 49.85 | 47.25 |
Forfeited (price per share) | | | | 85.77 | 80.12 |
Outstanding at September 30 (2) (price per share) | [2] | $ 75.02 | $ 67.67 | 75.02 | 67.67 |
Weighted average grant price for stock options/SARs vested or expected to vest (price per share) | [3] | 74.60 | 67.22 | 74.60 | 67.22 |
Stock Options and SARs Exercisable at September 30 (price per share) | [4] | $ 66.46 | $ 57.34 | 66.46 | 57.34 |
ESPP [Member] | | | | | |
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract] | | | | | |
Weighted Average Fair Value of Grants (price per share) | | | | $ 19.28 | $ 21.40 |
Expected Volatility (in hundredths) | | | | 36.54% | 32.54% |
Risk-Free Interest Rate (in hundredths) | | | | 0.43% | 0.12% |
Dividend Yield (in hundredths) | | | | 0.82% | 0.72% |
Expected Life (in years) | | | | 6 months | 6 months |
Restricted Stock And Restricted Stock Units [Member] | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | |
Unrecognized compensation expense | | $ 170.3 | | $ 170.3 | |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | | | | 2 years 9 months 18 days | |
Share-Based Compensation Arrangement By Restricted Stock And Restricted Stock Units Compensation Cost | | $ 13.1 | $ 16.2 | $ 45.5 | $ 53.9 |
Restricted Stock/Restricted Stock Units and Performance Units/Performance Stock [Roll Forward] | | | | | |
Outstanding at January 1 (in shares) | | | | 4,908,000 | 5,394,000 |
Granted (in shares) | | | | 833,000 | 1,036,000 |
Released (1) (in shares) | [5] | | | (1,392,000) | (1,250,000) |
Forfeited (in shares) | | | | (269,000) | (152,000) |
Outstanding at September 30 (2) (in shares) | [6] | 4,080,000 | 5,028,000 | 4,080,000 | 5,028,000 |
Weighted Average Grant Price Restricted Stock and Restricted Stock Units/Performance Units and Performance Stock [Roll Forward] | | | | | |
Outstanding at January 1 (price per share) | | | | $ 70.35 | $ 64.39 |
Granted (price per share) | | | | 87.76 | 77.90 |
Released (1) (price per share) | [5] | | | 53.15 | 51.02 |
Forfeited (price per share) | | | | 76.40 | 74.83 |
Outstanding at September 30 (2) (price per share) | [6] | $ 79.37 | $ 70.18 | $ 79.37 | 70.18 |
Performance Units and Performance Stock [Member] | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | |
Unrecognized compensation expense | | $ 7.4 | | $ 7.4 | |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | | | | 3 years 3 months 18 days | |
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract] | | | | | |
Weighted Average Fair Value of Grants (price per share) | | | | $ 112.09 | $ 80.64 |
Expected Volatility (in hundredths) | | | | 32.01% | 29.35% |
Risk-Free Interest Rate (in hundredths) | | | | 0.89% | 1.07% |
Term Of Zero- Coupon Risk- Free Interest Rate In Years Derived From Treasury Constant Maturities Yield Curve | | | | 3 years 3 months | |
Restricted Stock/Restricted Stock Units and Performance Units/Performance Stock [Roll Forward] | | | | | |
Outstanding at January 1 (in shares) | | | | 405,000 | |
Granted (in shares) | | | | 71,805 | |
Released (1) (in shares) | | | | (134,016) | |
Outstanding at September 30 (2) (in shares) | | 485,345 | | 485,345 | |
Weighted Average Grant Price Restricted Stock and Restricted Stock Units/Performance Units and Performance Stock [Roll Forward] | | | | | |
Aggregate intrinsic value of stock and units outstanding | | $ 46.9 | | $ 46.9 | |
Intrinsic value of stock and units released during the year | | | | $ 9.7 | |
Performance Units and Performance Stock [Abstract] | | | | | |
Additional Performance Awards Granted | | | | 142,556 | |
Minimum Performance Units and Stock Allowed to be Outstanding | | | | 151,096 | |
Share-Based Compensation Arrangement By Performance Units and Performance Stock Compensation Cost | | 5.7 | $ 4.1 | $ 6.6 | $ 4.8 |
Maximum Performance Units and Stock Allowed to be Outstanding | | | | 819,594 | |
Maximum Vest Period from the Date of Grant | | | | 5 years | |
Performance Period for Performance units and shares | | | | 3 years | |
Minimum Performance Multiple at the Completion of the Performance Period | | | | 0.00% | |
Maximum Performance Multiple at the Completion of the Performance Period | | | | 200.00% | |
Lease And Well [Member] | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | |
Compensation expense related to the company's stock-based compensation plans | | 8.9 | 10.3 | $ 28.2 | 32.9 |
Gathering And Processing Costs [Member] | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | |
Compensation expense related to the company's stock-based compensation plans | | 0.4 | 0.4 | 1 | 1 |
Exploration Costs [Member] | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | |
Compensation expense related to the company's stock-based compensation plans | | 4.1 | 6 | 15.6 | 19.3 |
General And Administrative [Member] | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | |
Compensation expense related to the company's stock-based compensation plans | | $ 24.2 | $ 23.6 | $ 52.3 | $ 48.8 |
| |
[1] | The total intrinsic value of stock options/SARs exercised for the nine months ended September 30, 2016 and 2015 was $58.7 million and $52.4 million, respectively. The intrinsic value is based upon the difference between the market price of EOG's common stock on the date of exercise and the grant price of the stock options/SARs. | |
[2] | The total intrinsic value of stock options/SARs outstanding at September 30, 2016 and 2015 was $240.8 million and $136.9 million, respectively. At September 30, 2016 and 2015, the weighted average remaining contractual life was 4.1 years and 4.4 years, respectively. | |
[3] | The total intrinsic value of stock options/SARs vested or expected to vest at September 30, 2016 and 2015 was $237.2 million and $135.7 million, respectively. At September 30, 2016 and 2015, the weighted average remaining contractual life was 4.0 years and 4.3 years, respectively. | |
[4] | The total intrinsic value of stock options/SARs exercisable at September 30, 2016 and 2015 was $196.3 million and $121.6 million, respectively. At September 30, 2016 and 2015, the weighted average remaining contractual life was 2.8 years and 3.1 years, respectively. | |
[5] | The total intrinsic value of restricted stock and restricted stock units released for the nine months ended September 30, 2016 and 2015 was $116.3 million and $102.5 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date the restricted stock and restricted stock units are released. | |
[6] | The total intrinsic value of restricted stock and restricted stock units outstanding at September 30, 2016 and 2015 was $394.6 million and $366.0 million, respectively. | |